Livingstone Health Swings to S$0.6M Profit on Higher Revenue and Operational Gains in FY2025
Summary:
-
Revenue rose 9% to S$27.6 million in FY2025, driven by growth across Specialist Healthcare, Primary Healthcare, and other segments.
-
The Group posted a net profit of S$0.6 million, reversing a net loss of S$2.9 million in FY2024.
-
Net operating cash flows surged to S$4.3 million from S$0.9 million a year ago.
-
Total loans and borrowings reduced by S$2.7 million to S$2.0 million.
-
Completed acquisition of remaining 49% in Phoenix Medical Group (PMG), expanding primary care network to 8 clinics.
-
Invested in a new endocrinology clinic (30% stake) and launched a specialised nerve and muscle diagnostics clinic.
-
Raised ~S$2.8 million via share placements and rights-cum-warrants issues; secured S$3.0 million term loan for acquisitions and working capital.
-
Looking ahead, the Group aims to recruit more specialists, expand its patient base, and explore strategic partnerships to attract international patients.